TagTreatment as Prevention (TasP)

Join Dr. Nneka Nwokolo in discussion of health issues faced by women living with HIV

J

ViiV Healthcare, July 2023 Join in the discussion with Dr Nneka Nwokolo on health issues faced by women living with HIV.  Dr Nwokolo is Head of Global Patient Affairs at ViiV Healthcare and an honorary Consultant Physician in Sexual Health and HIV Medicine at Chelsea and Westminster Hospital in London where she continues to see patients in a combined general and menopause clinic. Date & time:...

Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence

T

van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, Leleux O, Salmon D, Bonnet F, Matthews G, Doyle JS, Spelman T, Klein MB, Prins M, Asselin J, Stoové MA, Hellard M; InCHEHC study group. Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus...

Report: Adelaide Gay Community Periodic Survey, 2022

R

UNSW, June 2022 The report on the 2022 Adelaide Gay Community Periodic Survey has been published. The Gay Community Periodic Surveys (GCPS) are repeated, cross-sectional surveys of gay men conducted in the metropolitan areas of seven Australian states and territories. They are a key part of Australia’s behavioural surveillance system for HIV, monitoring sexual practices, drug use and patterns of...

Treatment as prevention works: HIV infections down by 66 per cent in NSW and Victoria

T

Kirby Institute, UNSW, 17th April 2023 A ten-year study into the impact of HIV ‘treatment as prevention’ has found that a 27 per cent increase in people accessing effective HIV treatment saw HIV infections decrease by 66 per cent between 2010 to 2019, in NSW and Victoria.  The findings, published today in Lancet HIV, show the success of HIV treatment as prevention in reducing new HIV infections...

Update: Changes to HIV treatment access for people ineligible for Medicare

U

NAPWHA, ASHM, AFAO,  May 2022 From 1st July, people with HIV who are ineligible for Medicare, and who previously received HIV medication through compassionate access schemes, will be required to transition to alternative access arrangements in order to receive government-funded treatment*. Option 1: individuals will need to engage in care with a public hospital-based physician and have their...

Agenda 2025: Ending HIV transmission in Australia in four years

A

Australian Federation of AIDS Organisations (AFAO), 17th June 2021 Agenda 2025 is a fully costed plan which draws upon evidence based research and is backed by top researchers, leaders, and clinicians in Australia’s community-led HIV response.  Australia can end HIV transmission within four short years, averting over 6,000 infections by 2030 and saving $1.4 billion in health costs, according to a...

Your sidebar area is currently empty. Hurry up and add some widgets.